Genomic & Biopharma News

Georgia State professor receives $1.2 million grant to study how the brain controls eating behavior
Dr. Marise Parent, professor and associate director of the Neuroscience Institute at Georgia State University, has received a three-year, $1.2 million federal grant to study how brain areas involved in memory control eating behavior.
News Medical Life Sciences, 2018-11-15 02:57:27

Scientists harness power of natural killer cells to treat children with neuroblastoma
Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer (NK) cells has shown promise as a treatment option to target and kill cancer cells in a less toxic way than conventional therapies.
News Medical Life Sciences, 2018-11-15 02:54:41

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Age-related decline in abstract reasoning ability predicts depressive symptoms over time
Age-related declines in abstract reasoning ability predict increasing depressive symptoms in subsequent years, according to data from a longitudinal study of older adults in Scotland. The research is published in Psychological Science, a journal of the Association for Psychological Science.
News Medical Life Sciences, 2018-11-15 02:49:01

Rainforest vine compound makes pancreatic cancer cells susceptible to nutrient starvation
Pancreatic cancer cells are known for their ability to thrive under extreme conditions of low nutrients and oxygen, a trait known in the cancer field as "austerity." The cells' remarkable resistance to starvation is one reason why pancreatic cancer is so deadly.
News Medical Life Sciences, 2018-11-15 02:42:38

Microgel powder reduces infection and promotes healing
While making smart glue, a team of engineers discovered a handy byproduct: hydrogen peroxide. In microgel form, it reduces bacteria and virus ability to infect by at least 99 percent.
News Medical Life Sciences, 2018-11-15 02:39:11

Human Cell Atlas study of early pregnancy shows how mother's immune system is modified
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta.
News Medical Life Sciences, 2018-11-15 02:33:02

Researchers evaluate efficacy of salivary biomarkers for early detection of oral cancer
Over 90% of malign tumors in the head and neck are originated from carcinomas of squamous cells that appear in superficial areas of the oral cavity. Their detection with salivary biomarkers can contribute to their early treatment, before they transform into tumors.
News Medical Life Sciences, 2018-11-15 02:24:05

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

U.K.’s Medicines Discovery Catapult partners to reduce use of animals in research
U.K. startup supporter Medicines Discovery Catapult is partnering with the National Centre for the Replacement, Refinement & Reduction of Animals in Research.
Fierce Biotech, 2018-11-14 19:48:01

Nektar nabs Genentech I-O leader Wei Lin to head up its oncology programs
Nektar Therapeutics has poached Genentech cancer immunotherapy leader Wei Lin, M.D., to head up its oncology program and serve as VP of clinical development as it moves forward with its phase 3 trial with its lead combination therapy.
Fierce Biotech, 2018-11-14 19:23:54